Mayelana-umdlavuza / ukwelashwa / izidakamizwa / i-myeloproliferative-neoplasms

Izidakamizwa zivunyelwe i-Myeloproliferative Neoplasms

Leli khasi libala imishanguzo yomdlavuza evunyelwe yi-Food and Drug Administration (i-FDA) yamaphaphu we-myeloproliferative neoplasms. Uhlu lufaka amagama ajwayelekile nawomkhiqizo. Leli khasi futhi libala izinhlanganisela zezidakamizwa ezivamile ezisetshenziswe kuma-neoplasms we-myeloproliferative. Izidakamizwa ngazinye ezinhlanganisweni zivunyelwe yi-FDA. Kodwa-ke, ukuhlanganiswa kwezidakamizwa uqobo ngokwazo akuvunyelwe, kepha kusetshenziswa kabanzi.

Amagama ezidakamizwa axhumanisa nezifinyezo ze-Cancer Information Information ze-NCI. Kungaba nezidakamizwa ezisetshenziswe kuma-myeloproliferative neoplasms angabhalisiwe lapha.

Izidakamizwa zivunyelwe i-Myeloproliferative Neoplasms

I-Adriamycin PFS (iDoxorubicin Hydrochloride)

I-Adriamycin RDF (iDoxorubicin Hydrochloride)

I-Arsenic Trioxide

I-Azacitidine

I-Cerubidine (Daunorubicin Hydrochloride)

I-Clafen (Cyclophosphamide)

ICyclophosphamide

ICytarabine

I-Cytosar-U (Cytarabine)

ICytoxan (iCyclophosphamide)

I-Dacogen (Decitabine)

I-Dasatinib

I-Daunorubicin Hydrochloride

I-Decitabine

I-Doxorubicin Hydrochloride

I-Fedratinib Hydrochloride

I-Gleevec (Imatinib Mesylate)

Imatinib Mesylate

I-Inrebic (Fedratinib Hydrochloride)

I-Jakafi (Ruxolitinib Phosphate)

UNilotinib

I-Rubidomycin (Daunorubicin Hydrochloride)

I-Ruxolitinib Phosphate

I-Sprycel (Dasatinib)

I-Tarabine PFS (Cytarabine)

Isi-Tasigna (Nilotinib)

I-Trisenox (i-Arsenic Trioxide)

Isi-Vidaza (Azacitidine)

Ukuhlanganiswa Kwezidakamizwa Kusetshenziswe kumaMyoplasms we-Myeloproliferative

I-ADE